Sedona Sweeney

2.5k total citations
62 papers, 1.4k citations indexed

About

Sedona Sweeney is a scholar working on Infectious Diseases, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Sedona Sweeney has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 21 papers in Epidemiology and 21 papers in Economics and Econometrics. Recurrent topics in Sedona Sweeney's work include Tuberculosis Research and Epidemiology (21 papers), Global Maternal and Child Health (17 papers) and Health Systems, Economic Evaluations, Quality of Life (16 papers). Sedona Sweeney is often cited by papers focused on Tuberculosis Research and Epidemiology (21 papers), Global Maternal and Child Health (17 papers) and Health Systems, Economic Evaluations, Quality of Life (16 papers). Sedona Sweeney collaborates with scholars based in United Kingdom, United States and South Africa. Sedona Sweeney's co-authors include Anna Vassall, Carol Dayo Obure, GS Firestein, Deepa Hammaker, Fern Terris‐Prestholt, Robert Greener, Karl L. Dehne, Claudia B. Maier, Lorna Guinness and Nicolas A. Menzies and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Social Science & Medicine.

In The Last Decade

Sedona Sweeney

59 papers receiving 1.4k citations

Peers

Countries citing papers authored by Sedona Sweeney

Since Specialization

Citations

This map shows the geographic impact of Sedona Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sedona Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sedona Sweeney more than expected).

Fields of papers citing papers by Sedona Sweeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sedona Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sedona Sweeney. The network helps show where Sedona Sweeney may publish in the future.

Co-authorship network of co-authors of Sedona Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Sedona Sweeney. A scholar is included among the top collaborators of Sedona Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sedona Sweeney. Sedona Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysis 2025 ·The Lancet Global Health ·(unknown), Sedona Sweeney, Brian Allwood, Susan E. Dorman, Ted Cohen, Nicolas A. Menzies	0
2	Selecting Cost-Effectiveness Methods for Health Benefits Package Design: A Systematic Approach 2025 ·International Journal of Health Policy and Management ·(unknown), Sedona Sweeney, Rob Baltussen, Anna Vassall	0
3	Unit costs and cost-effectiveness of a device to improve TB treatment adherence in China 2024 ·SHILAP Revista de lepidopterología ·Sedona Sweeney, Katherine Fielding, (unknown), JA Thompson, Hongwei Dong, Shaofeng Jiang, Yanlin Zhao, Huan Shi, Anna Vassall	1
4	Estimating the health and macroeconomic burdens of tuberculosis in India, 2021–2040: A fully integrated modelling study 2024 ·PLoS Medicine ·Marcus Keogh-Brown, Tom Sumner, Sedona Sweeney, Anna Vassall, Henning Tarp Jensen	2
5	Uncertainty in tuberculosis clinical decision-making: An umbrella review with systematic methods and thematic analysis 2024 ·SHILAP Revista de lepidopterología ·(unknown), Sedona Sweeney, (unknown), Else M. Bijker, (unknown), Nicolas A. Menzies, Anna Vassall, Pitchaya Indravudh	1
6	Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis 2024 ·PLoS Medicine ·Lyndon P. James, Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F. Franke, Reza Yaesoubi, Dumitru Chesov, (unknown), (unknown), Valeriu Crudu, Ted Cohen, Nicolas A. Menzies	4
7	Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis 2024 ·The Lancet Global Health ·Theresa Ryckman, Samuel G. Schumacher, Christian Lienhardt, Sedona Sweeney, David W. Dowdy, Fuad Mirzayev, Emily A. Kendall	6
8	Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial 2023 ·The Lancet Global Health ·Xiaoqiu Liu, JA Thompson, (unknown), Sedona Sweeney, Xue Li, Yanli Yuan, Xiaomeng Wang, (unknown), Bruce Thomas, Caihong Xu, Dongmei Hu, Anna Vassall, Shitong Huan, Hui Zhang, Shiwen Jiang, Katherine Fielding, Yanlin Zhao	28
9	Adaptive Health Technology Assessment: A Scoping Review of Methods 2023 ·Value in Health ·(unknown), Hiral Shah, (unknown), (unknown), (unknown), (unknown), Javier Guzmán, Sedona Sweeney, Francis Ruiz, Anna Vassall	9
10	COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness 2021 ·PLoS Medicine ·Carl A. B. Pearson, Fiammetta Bozzani, Simon R. Procter, Nicholas G. Davies, (unknown), Henning Tarp Jensen, Marcus Keogh-Brown, (unknown), Sedona Sweeney, Sergio Torres‐Rueda, (unknown), (unknown), Rosalind M. Eggo, Anna Vassall, Mark Jit	34
11	Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae 2021 ·The Lancet Global Health ·Nicolas A. Menzies, Matthew Quaife, Brian Allwood, Anthony Byrne, Anna K. Coussens, Anthony Harries, Florian M. Marx, Jamilah Meghji, Debora Pedrazzoli, Joshua A. Salomon, Sedona Sweeney, Sanne van Kampen, Robert S. Wallis, Rein M G J Houben, Ted Cohen	114
12	Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy 2020 ·BMJ Open ·Sedona Sweeney, Gabriela B. Gomez, (unknown), Animesh A. Sinha, (unknown), Suzanne Staples, Ronelle Moodliar, (unknown), (unknown), Mohammed Rassool, Nosipho Ngubane, (unknown), Bern-Thomas Nyang’wa	8
13	Evaluating the cost‐effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs 2019 ·Addiction ·Sedona Sweeney, Zoë Ward, Lucy Platt, Lorna Guinness, Matthew Hickman, Vivian Hope, Lisa Maher, Jenny Iversen, Sharon Hutchinson, Josie Smith, Rachel Ayres, (unknown), Peter Vickerman	22
14	Impact of current and scaled‐up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets? 2018 ·Addiction ·Zoë Ward, Lucy Platt, Sedona Sweeney, Vivian Hope, Lisa Maher, Sharon Hutchinson, Norah Palmateer, Josie Smith, Noel Craine, Avril Taylor, Natasha K. Martin, Rachel Ayres, John Dillon, Matthew Hickman, Peter Vickerman	23
15	Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial 2018 ·Trials ·James Lewis, Xiaoqiu Liu, Zhiying Zhang, Bruce Thomas, Anna Vassall, Sedona Sweeney, Caihong Xu, Dongmei Hu, Li Xue, (unknown), Shitong Huan, Shiwen Jiang, Katherine Fielding	15
16	Measuring income for catastrophic cost estimates: Limitations and policy implications of current approaches 2018 ·Social Science & Medicine ·Sedona Sweeney, (unknown), (unknown), Lorna Guinness, Alison D. Grant, Anna Vassall	29
17	Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study 2017 ·PLoS Medicine ·William E. Rudgard, Carlton A. Evans, Sedona Sweeney, Tom Wingfield, Knut Lönnroth, Dráurio Barreira, Delia Boccia	37
18	Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis 2016 ·BMC Infectious Diseases ·Gabriela B. Gomez, David W. Dowdy, Mayara Lisboa Bastos, Alice Zwerling, Sedona Sweeney, Nicola Foster, Anete Trajman, Md. Akramul Islam, Saidi Kapiga, Edina Sinanovic, Gwenan M. Knight, Richard G. White, William A. Wells, Frank Cobelens, Anna Vassall	26
19	The cost‐effectiveness of 10 antenatal syphilis screening and treatment approaches in Peru, Tanzania, and Zambia 2015 ·International Journal of Gynecology & Obstetrics ·Fern Terris‐Prestholt, Peter Vickerman, Sergio Torres‐Rueda, Nancy Santesso, Sedona Sweeney, (unknown), Katharine D. Shelley, Patricia García, Rachel N. Bronzan, Michelle M. Gill, Nathalie Broutet, Teodora Wi, Charlotte Watts, David Mabey, Rosanna Ŵ. Peeling, Lori M. Newman	24
20	Point-of-Care Tests to Strengthen Health Systems and Save Newborn Lives: The Case of Syphilis 2012 ·PLoS Medicine ·David Mabey, Kimberly A. Sollis, Helen Kelly, Adele Schwartz Benzaken, Edward Bitarakwate, John Changalucha, Xiang‐Sheng Chen, Yue-Ping Yin, Patricia García, Susan Strasser, Namwinga Chintu, Tikki Pang, Fern Terris‐Prestholt, Sedona Sweeney, Rosanna Ŵ. Peeling	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact